Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SKVI
this stock
Skinvisible, Inc.
|
$972,692 | -21.9% | +0.0% | — | 0.2% |
|
PG
PROCTER & GAMBLE Co
|
$389.46B | +17.2% | +3.3% | 25.3 | 1.0% |
|
UL
Unilever PLC
|
$142.19B | +1.0% | — | — | 0.0% |
|
CL
Colgate Palmolive Co
|
$77.82B | +23.9% | +1.7% | 38.2 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$47.61B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SKVI | -11.3% | -18.2% | -39.4% | +15.2% | -21.9% |
| SPY | -0.6% | -3.6% | +1.2% | -0.8% | +10.0% |
| vs SPY | -10.7% | -14.6% | -40.6% | +16.0% | -31.9% |
